NVDA+2.54%AAPL+1.32%GOOGL−1.62%MSFT+0.20%AMZN−0.10%TSM+1.60%SPCX+7.79%META+0.47%
StockVS

NASDAQ · Specialty Chemicals · USD

Calumet, Inc. (CLMT) Stock Analysis

Calumet, Inc. (CLMT) is a Specialty Chemicals stock listed on NASDAQ and quoted in US Dollar.

Last Updated: October 21, 2026

CLMT

$52.59

−$3.46 (−6.17%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare CLMT with… →

CLMT Key Statistics

As of Oct 21, 2026
Trading
Open
$56.31
Previous Close
$56.05
Day's Range
51.99–56.43
52-Week Range
17.75–59.87
Volume
1.93M
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.78
Valuation
Market Cap
$5.15B
P/E Ratio
unprofitable
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
93.00
PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
0.65
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
1.12
EPS (ttm)Profit attributable to each share over the last twelve months.
−1.55
Financials (FY)
Revenue (FY)
$4.14B−1.25%
Net Income (FY)
−$33.80M
Profit marginThe share of revenue left as profit after all costs and taxes.
−2.98%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
87.90M
1-Year Return
+181.68%
Dividend and dates
Earnings Date
November 6, 2026
Avg Volume
1.33M

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, CLMT closed at $52.59, +181.68% over 1 year.

Calumet, Inc. (CLMT) has a market capitalization of $5.15B.

In fiscal 2025, CLMT reported revenue of $4.14B.

CLMT Stock Return by Calendar Year

Calumet, Inc. (CLMT) 10-year return: what $10,000 became

1 year
$10,000 $28,168
+181.68%
5 years
$10,000 $47,124
+371.24%
10 years
$10,000 $128,268
+1,182.68%

If you had invested $10,000 in Calumet, Inc. (CLMT) 10 years ago, at the close on October 21, 2016, it would have been worth $128,268 at the close on October 21, 2026: +1,182.68% in total, +29.07% a year. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+164.67%
2025−9.76%
2024+23.22%
2023+5.86%
2022+27.88%
2021+321.73%
2020−14.25%
2019+65.16%
2018−71.30%
2017+92.50%
2016 (partial year)−20.16%

As of October 21, 2026.

CLMT Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$4.14B−$33.80M−0.8%
2024$4.19B−$222.00M−5.3%
2023$4.18B$48.10M1.2%
2022$4.69B−$173.30M−3.7%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$4.14B$245.70M$54.20M−$33.80M−0.8%
2024$4.19B$230.80M$10.10M−$222.00M−5.3%
2023$4.18B$451.70M$270.70M$48.10M1.2%
2022$4.69B$351.70M$132.60M−$173.30M−3.7%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

CLMT Valuation vs Specialty Chemicals Median

Median of 70 stocks
MetricCLMTSpecialty Chemicals medianvs median
P/S ratio1.121.5930% below
Profit margin−2.98%2.70%5.7 pts below

Medians across 70 Specialty Chemicals stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Recent News

All 20 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The market values Calumet, Inc. (CLMT) at $5.15B. It is classified in the Specialty Chemicals industry, within the Basic Materials sector. Headcount on file is 1,540.

Over the past 52 weeks the price has ranged from $17.75 to $59.87. The most recent close on file for CLMT is $52.59, dated October 21, 2026. That is −$3.46 (−6.17%) against the previous close. The latest close sits 196.28% above that 52-week low.

Financial Health

The most recent full year on file, fiscal 2025, shows revenue of $4.14B. That is −1.25% against the prior fiscal year, when revenue was $4.19B. The same year closed with a net loss of $33.80M. Profit margin runs at −2.98%. That is 5.7 percentage points below the Specialty Chemicals median of 2.7%. Earnings per share on a trailing basis come to −1.55.

Across the 4 fiscal years on file, revenue moves from $4.69B in 2022 to $4.14B in 2025. Of those 4 years, 1 report positive net income.

Valuation Assessment

No trailing P/E applies: the last reported earnings figure is negative. The forward P/E on file is 93. The PEG ratio, which sets the P/E against expected earnings growth, reads 0.65. The price-to-sales ratio is 1.12. On price-to-sales that is 29.63% below the Specialty Chemicals median of 1.59. 70 Specialty Chemicals companies report these metrics, and the medians quoted come from that group.

Over the trailing twelve months the total return is +181.68%. Across 10 years the annualized return works out at +29.07%. Beta against the wider market is reported at 0.78. Daily returns over the trailing 10 years annualize to a volatility of 65.02%.

Growth & Income

No dividend is on file for CLMT.

So far in 2026 the total return is +164.67%. The strongest complete calendar year on file is 2021 at +321.73%; the weakest is 2018 at −71.30%. Of the 9 complete calendar years on file, 6 finished higher.

Peer Comparison

Calumet, Inc. (CLMT) operates in the Specialty Chemicals industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Calumet, Inc. CLMT $5.15B —
Linde plc LIN $230.75B 32.3
The Sherwin-Williams Company SHW $81.88B 31.1
Ecolab Inc. ECL $80.76B 38.7

The Specialty Chemicals industry average P/E ratio is 28.3x. Calumet, Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Specialty Chemicals Stocks

LIN

Linde plc

$230.75B

 SHW

The Sherwin-Williams Company

$81.88B

 ECL

Ecolab Inc.

$80.76B

 APD

Air Products and Chemicals, Inc.

$67.40B

 PPG

PPG Industries, Inc.

$24.49B

 IFF

International Flavors & Fragrances Inc.

$23.23B
View all Specialty Chemicals stocks →

Popular Basic Materials Stocks

BHP

BHP Group Limited

$211.50B

 SCCO

Southern Copper Corporation

$167.24B

 RIO

Rio Tinto Group

$141.37B

 NEM

Newmont Corporation

$123.47B

 FCX

Freeport-McMoRan Inc.

$98.94B
View all Basic Materials stocks →

About Calumet, Inc.

Calumet, Inc. manufactures, formulates, and markets a slate of specialty branded products and renewable fuels in North America and internationally. It operates through Specialty Products and Solutions; Performance Brands; and Montana/Renewables segments. The Specialty Products and Solutions segment manufactures and markets various solvents, waxes, customized lubricating oils, white oils, petrolatums, gels, esters, and other products. The Montana/Renewables segment processes geographically advantaged renewable feedstocks into renewable diesel, aviation fuel, and renewable naphtha. This segment also engages in the process of Canadian crude oil into conventional gasoline, diesel, jet fuel, and specialty grades of asphalt. The Performance Brands segment blends, packages, and markets high performance products through Royal Purple, Bel-Ray, and TruFuel brands. It serves wholesale distributors and retail chains. Calumet, Inc. was founded in 1919 and is headquartered in Indianapolis, Indiana.

Visit website →